CXCL10 and melanoma: Likewise, CXCL10 has been shown to repulse plasmacytoid dendritic cells [38]; interestingly CXCL10 has also been shown to inhibit angiogenesis [39]–[41] and overexpression or mutation of CXCL10 in melanoma cells results in slower growth of xenografts [41], [42].